BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 20, 2010
View Archived Issues
Bezafibrate-medroxyprogesterone combination active against AML
Read More
MAC-13243 represents a new antibacterial class with Gram-negative selectivity
Read More
Neural stem cells used to deliver HER2-targeting antibodies
Read More
Glucobay OD approved in Japan for diabetes
Read More
Date set for FDA Advisory Committee review of tesamorelin
Read More
Genzyme reports fourth quarter 2009 results
Read More
Boehringer and Priaxon sign collaboration for mdm2/p53 inhibitors in cancer
Read More
Founders of Proteon Therapeutics launch new company Novita Therapeutics
Read More
Viralytics reports results from phase I trial of Cavatak in late-stage melanoma
Read More
Lecithin-based nanoparticle adjuvant induces antibody immune responses
Read More
Polylactide-co-glycolide cancer vaccine regulates dendritic cell network for antitumor responses
Read More
Idera achieves clinical milestone under Merck collaboration for cancer treatment
Read More
Abbott claims nicotinic alpha4beta2 receptor modulators as analgesics
Read More
New compounds for the treatment of neurodegeneration claimed by sanofi-aventis
Read More
Novel oncolytic agents described by Bristol-Myers Squibb
Read More
Ranbaxy acquires vaccine products and manufacturing facility from Biovel
Read More
MorphoSys enrolls first patient in phase Ib/IIa clinical trial for MOR-103
Read More
AstraZeneca claims mGluR2 agonists for the treatment of schizophrenia
Read More
Depomed plans for one additional phase III trial for menopausal hot flashes
Read More
Biotie reports topline data from VAP-1 antibody trial in RA patients
Read More
RXi and UMMS sign research collaboration for sd-rxRNA in ocular diseases
Read More
Merz and BioForm Medical sign agreement and plan of merger
Read More
GenVec enters collaboration for hearing loss treatments
Read More
Avir Green Hills Biotechnology commences phase II deltaFLU study
Read More
